Simple Summary Tyrosine kinase inhibitors and immune checkpoint inhibitors have
substantially prolonged survival in patients affected by advanced renal cell carcinoma …

Background Tyrosine kinase receptor family is involved in tumor growth, pathological
angiogenesis and the progression (metastasis) of cancer. Sunitinib (Sutent®) inhibits …

Purpose Survival time after bisphosphonate use has been increasingly recognized to be
associated with the incidence of medication-related osteonecrosis of the jaw (MRONJ); …

Osteonecrosis is a debilitating condition characterized by the loss of blood supply to the
bones, leading to bone death. This condition can impact various bones, including the jaw …

Evaluation of Prevalence and Positions of Mesiodens Using Cone-Beam Computed
Tomography - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Background Oral chemotherapy use is increasing due to new drug approvals as well as the
convenience of the administration of oral drugs. This increased use also raises concern …

Osteonecrosis of the jaw (ONJ) is a rare but very serious disease that can affect both jaws. It
is defined as exposed bone in the maxillofacial region that does not heal within 8 weeks …

Objective To optimize the use of tyrosine kinase inhibitors (TKIs) and immune checkpoint
inhibitors (ICIs) for cancer patients, we characterized and evaluated ONJ related to TKIs and …

Background This case report shows an affected postmenopausal patient with medicaments
related osteonecrosis of the jaw injury associated with increased use of bisphosphonates …

Os bisfosfonatos (BFs) foram sintetizados pela primeira vez nos anos 1800, mas somente
nas últimas 4 décadas eles foram usados para tratar distúrbios do metabolismo do cálcio …